XML 104 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss from continuing operations $ (14,361,000) $ (14,787,000)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:    
Depreciation and amortization 6,425,000 1,335,000
Gain on allowance for obsolescence of inventory (280,000)
Stock based compensation 4,000 (15,000)
Loss on equity method investment 211,000 911,000
Loss (gain) on investments (3,823,000) 7,898,000
Change in ROU assets and lease liabilities, net (80,000)
Gain on extinguishment of debt (110,000) (116,000)
Deferred tax benefit (2,693,000)
Accretion of debt discount, origination fee and prepaid interest (1,698,000)
Gain on sale of assets (405,000)
Impairment of notes receivable and other investments 1,745,000
Decrease (increase) in assets:    
Accounts receivable (460,000) 366,000
Inventory (591,000) (1,265,000)
Prepaid expenses and other current assets 1,307,000 (559,000)
Other assets (312,000) 112,000
Increase (decrease) in liabilities:    
Accounts payable 192,000 159,000
Accrued expenses (3,036,000) 802,000
Other liabilities (373,000) (698,000)
Net cash used by operating activities (13,947,000) (10,248,000)
Cash flows from investing activities:    
Purchase of property, plant and equipment (976,000) (1,263,000)
Purchase of real estate (689,000) (6,565,000)
Purchase of investment (18,114,000)
Purchase of marketable securities (4,805,000) (8,789,000)
Disposal of property, plant and equipment 2,557,000
Purchase of equity investment (400,000)
Sale of marketable securities 9,185,000
Issuance of new notes receivable (3,362,000) (18,799,000)
Payments received on notes receivable 863,000
Purchase of intangible assets (585,000)
Net cash used by investing activities (6,412,000) (45,330,000)
Cash flows from financing activities:    
Payments of long-term debt (169,000) (81,000)
Borrowings of long-term debt 6,360,000 6,328,000
Deferred financing fees (186,000)
Issuances of common stock, net of issuance costs 1,518,000 106,772,000
Net cash provided by financing activities 7,709,000 112,833,000
Cash flows from discontinued operations:    
Cash provided by discontinued operations 161,000
Cash provided by investing activities 3,046,000
Net cash used by discontinued operations 3,207,000
Net increase (decrease) in cash (12,650,000) 60,462,000
Cash and cash equivalents at beginning of period 56,595,000 5,183,000
Cash and cash equivalents at end of period $ 43,945,000 $ 65,645,000